Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure safe and effective even when donors and…

Continue Reading

News Source: medicalxpress.com